Westmount Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Sell
9,734
-1,581
-14% -$368K 0.54% 41
2026
Q1
$2.77M Buy
11,315
+1,272
+13% +$296K 0.68% 30
2025
Q4
$2.08M Buy
10,043
+129
+1% +$25.5K 0.52% 43
2025
Q3
$1.84M Sell
9,914
-2,890
-23% -$495K 0.48% 45
2025
Q2
$1.96M Sell
12,804
-339
-3% -$52.1K 0.54% 44
2025
Q1
$2.18M Sell
13,143
-814
-6% -$127K 0.66% 34
2024
Q4
$2.02M Sell
13,957
-287
-2% -$44.5K 0.61% 36
2024
Q3
$2.31M Sell
14,244
-23
-0.2% -$3.67K 0.69% 28
2024
Q2
$2.09M Buy
14,267
+276
+2% +$41K 0.69% 31
2024
Q1
$2.21M Sell
13,991
-365
-3% -$58.1K 0.8% 27
2023
Q4
$2.25M Buy
14,356
+80
+0.6% +$12.3K 0.92% 22
2023
Q3
$2.22M Buy
14,276
+870
+6% +$144K 0.98% 21
2023
Q2
$2.22M Buy
13,406
+134
+1% +$21.6K 0.97% 22
2023
Q1
$2.06M Buy
13,272
+145
+1% +$23.4K 0.95% 22
2022
Q4
$2.32M Buy
+13,127
New +$2.27M 1.2% 18

Other funds holding JNJ

Westmount Partners's JNJ Position: Q2 2026 in Review

Westmount Partners reduced its Johnson & Johnson (JNJ) stake by 14% in Q2 2026, selling an estimated $368K and leaving 9,734 shares worth $2.47M. The position accounts for 0.54% of the portfolio, ranked #41.

Westmount Partners first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.77M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Westmount Partners held 9,734 shares of Johnson & Johnson worth $2.47M as of Q2 2026.
  • Westmount Partners sold 1,581 Johnson & Johnson shares in Q2 2026, an estimated $368K.
  • Johnson & Johnson made up 0.54% of Westmount Partners's portfolio in Q2 2026, its #41 holding.
  • Westmount Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Westmount Partners's Johnson & Johnson position peaked at $2.77M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Westmount Partners's 13F filing for Q2 2026, filed 7 Jul 2026.